Ryan D Morin
Affiliations: | Simon Fraser University, Burnaby, British Columbia, Canada |
Area:
Human GeneticsGoogle:
"Ryan Morin"Children
Sign in to add trainee| Sarah Arthur | grad student | Simon Fraser | |
| Kristena Daley | grad student | Simon Fraser | |
| Christopher K. Rushton | grad student | Simon Fraser | |
| Kevin Bushell | grad student | 2013-2016 | Simon Fraser |
| Stephen Yu | grad student | 2014-2018 | Simon Fraser |
| Bruno M. Grande | grad student | 2013-2019 | Simon Fraser |
| Miguel Alcaide | post-doc | Simon Fraser | |
| Krysta Coyle | post-doc | Simon Fraser | |
| Laura K. Hilton | post-doc | Simon Fraser (Cell Biology Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Thomas N, García-Prieto CA, Dreval K, et al. (2025) DNA methylation epitypes of Burkitt lymphoma with distinct molecular and clinical features. Blood Cancer Discovery |
| Collinge B, Hilton LK, Wong J, et al. (2025) High-grade B-cell lymphoma, not otherwise specified: an LLMPP study. Medrxiv : the Preprint Server For Health Sciences |
| Coyle KM, Dreval K, Hodson DJ, et al. (2025) Audit of B-cell Cancer Genes. Blood Advances |
| Sahasrabuddhe AA, Chen X, Ma K, et al. (2025) The FBXO45-GEF-H1 axis controls germinal center formation and B-cell lymphomagenesis. Cancer Discovery |
| Collinge BJ, Ben-Neriah S, Hilton LK, et al. (2024) Unbalanced MYC break-apart FISH patterns indicate the presence of a MYC rearrangement in HGBCL-DH-BCL2. Blood |
| Hilton LK, Collinge BJ, Ben-Neriah S, et al. (2024) Motive and Opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements-an LLMPP study. Blood |
| Benoit A, Abraham MJ, Li S, et al. (2024) STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment. International Journal of Hematology |
| Hilton LK, Scott DW, Morin RD. (2023) Biological heterogeneity in diffuse large B-cell lymphoma. Seminars in Hematology |
| Sircar A, Singh S, Xu-Monette ZY, et al. (2023) Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma. Leukemia |
| Davies JR, Hilton LK, Jiang A, et al. (2023) Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL. Blood Advances |